PMV Pharmaceuticals, Inc. (PMVP)
Data as of , from SEC Form 4 filings.
See up to 3 months of PMVP. The 7-day demo opens the 1M and 3M ranges and puts PMVP on your watchlist.
Start 7-day demoLatest PMVP insider trades
About PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. files with the SEC under CIK 0001699382 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PMVP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 84,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PMVP insider transactions (Form 4)
3621 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Matthew Joseph Eckler - Director | Grant or award | Stock Option (right to buy) | 84,000 | $0.00 | - | |
| Laurie Stelzer | Grant or award | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Arnold J. Levine | Grant or award | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Carol Giltner Gallagher | Grant or award | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Carol Giltner Gallagher | Gift | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Carol Giltner Gallagher | Gift | Stock Option (right to buy) | 42,000 | $0.00 | - | |
 Kirsten Flowers | Grant or award | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Charles M. Baum | Grant or award | Stock Option (right to buy) | 42,000 | $0.00 | - | |
| Michael Carulli - Officer | Grant or award | Employee Stock Option (right to buy) | 240,000 | $0.00 | - | |
| Robert Ticktin - Officer | Grant or award | Employee Stock Option (right to buy) | 319,270 | $0.00 | - | |
| Deepika Jalota - Officer | Grant or award | Employee Stock Option (right to buy) | 303,310 | $0.00 | - | |
 David Henry Mack - Officer | Grant or award | Employee Stock Option (right to buy) | 744,960 | $0.00 | - | |
| David Henry Mack - Officer | Option exercise | Common Stock | 220,643 | $1.37 | $302K | |
| David Henry Mack - Officer | Option exercise | Employee Stock Option (right to buy) | 220,643 | $0.00 | - | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 1,000,000 | $1.52 | $1.52M | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market sale | Common Stock | 500,000 | $1.80 | $900K | |
| Deepika Jalota - Officer | Open-market sale | Common Stock | 33,065 | $1.06 | $35K | |
| Michael Carulli - Officer | Open-market sale | Common Stock | 28,249 | $1.06 | $30K | |
| Robert Ticktin - Officer | Open-market sale | Common Stock | 23,151 | $1.06 | $25K | |
| David Henry Mack - Officer | Open-market sale | Common Stock | 58,411 | $1.06 | $62K | |
| Arnold J. Levine | Grant or award | Stock Option (right to buy) | 33,500 | $0.00 | - | |
| Michael Carulli - Officer | Derivative | Employee Stock Option (right to buy) | 13,605 | - | - | |
| Michael Carulli - Officer | Derivative | Employee Stock Option (right to buy) | 27,200 | - | - | |
| Michael Carulli - Officer | Grant or award | Employee Stock Option (right to buy) | 40,805 | - | - | |
| Michael Carulli - Officer | Derivative | Employee Stock Option (right to buy) | 75,000 | - | - | |
| Michael Carulli - Officer | Grant or award | Employee Stock Option (right to buy) | 75,000 | - | - | |
| Deepika Jalota - Officer | Derivative | Employee Stock Option (right to buy) | 22,674 | - | - | |
| Deepika Jalota - Officer | Derivative | Employee Stock Option (right to buy) | 68,100 | - | - | |
| Deepika Jalota - Officer | Grant or award | Employee Stock Option (right to buy) | 90,774 | - | - | |
| Deepika Jalota - Officer | Derivative | Employee Stock Option (right to buy) | 125,000 | - | - | |
| Deepika Jalota - Officer | Grant or award | Employee Stock Option (right to buy) | 125,000 | - | - | |
| David Henry Mack - Officer | Derivative | Employee Stock Option (right to buy) | 134,584 | - | - | |
| David Henry Mack - Officer | Derivative | Employee Stock Option (right to buy) | 249,600 | - | - | |
| David Henry Mack - Officer | Grant or award | Employee Stock Option (right to buy) | 384,184 | - | - | |
| David Henry Mack - Officer | Derivative | Employee Stock Option (right to buy) | 330,000 | - | - | |
| David Henry Mack - Officer | Grant or award | Employee Stock Option (right to buy) | 330,000 | - | - |
PMVP insider trading FAQ
What is the latest insider trade for PMVP?
PMV Pharmaceuticals, Inc. (PMVP) had 1 insider filing in the last 90 days, with the most recent on 2026-10-05. The full record for PMVP runs to 21 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PMVP stock?
No insider purchases of PMVP were filed in the last 90 days.
How many insiders are selling PMVP stock?
No insider sales of PMVP were filed in the last 90 days. 6 sales are on record for this company.
Where can I see PMVP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PMVP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Matthew Joseph Eckler view on EDGAR
- - Laurie Stelzer view on EDGAR
- - Arnold J. Levine view on EDGAR
- - Carol Giltner Gallagher view on EDGAR
- - Kirsten Flowers view on EDGAR
- - Charles M. Baum view on EDGAR
- - Michael Carulli view on EDGAR
- - Robert Ticktin view on EDGAR
- - Deepika Jalota view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PMVP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PMVP with a 7-day demo
- PMVP on your watchlist
- Every PMVP Form 4 filing on record
- Up to 3 months of PMVP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
